Seattle Cancer Care Alliance (SCCA) provides comprehensive, leading-edge treatment for people diagnosed with melanoma. SCCA was formed, in part, to bring promising new treatments to patients faster. This means that people who have melanoma will find more treatment options at SCCA than might be found elsewhere, including participation in one of the clinical studies conducted at SCCA and its founding organizations, Fred Hutchinson Cancer Research Center and UW Medicine.
SCCA has a wide variety of clinical studies for melanoma patients, including vaccines, immune cell treatments, and other substances that stimulate the immune system. Our doctors are working toward being able to stage and characterize melanoma down to the molecular level. Defining the changes in the genetic material that cause different types of melanoma will help to identify patients whose melanoma may be more successfully treated with certain, more customized, regimens.
Learn more about melanoma in the pages linked on the left. Complete with photographs, you can learn about the symptoms and signs to look for regarding skin cancer.